Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Electrocardiographic and biochemical analysis of anthracycline induced cardiotoxicity in breast cancer patients from Southern Sri Lanka

Fig. 2

Comparison of echocardiographic parameters among the four time points. Baseline; One day prior to anthracycline chemotherapy, FTP I; One day after 1st dose of anthracycline chemotherapy, FTP II; One day after last dose of anthracycline chemotherapy, FTP III; Six months after completion of anthracycline chemotherapy. All values are expressed as mean ± SD (n = 196). p values *˂ 0.05, **˂ 0.01, ***˂0.001 compared to the baseline readings. (Paired t-test was applied to compare echocardiographic parameters between the baseline and one day and six months after the completion of anthracycline chemotherapy). FTP; Follow up time point, EF; ejection fraction, FS; fractioning shortening, PWT, LV; posterior wall thickness (left ventricle), IVS, LV; thickness of inter-ventricular septum (left ventricle), LVEDD; left ventricular end diastolic diameter, LVESD; left ventricular end systolic diameter, SD; standard deviation

Back to article page